CTRI Number |
CTRI/2023/10/058555 [Registered on: 12/10/2023] Trial Registered Prospectively |
Last Modified On: |
11/10/2023 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Surgical/Anesthesia |
Study Design |
Randomized, Parallel Group Trial |
Public Title of Study
|
Comparison of transdermal diclofenac patch with IM
diclofenac for post operative analgesia in lap chole |
Scientific Title of Study
|
Compare the efficacy of transdermal diclofenac patch with intramuscular
diclofenac for post op analgesia in laparoscopic cholecystectomy:Randomized Controlled Trial
|
Trial Acronym |
NIL |
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Himanshu Singh |
Designation |
Junior resident |
Affiliation |
Rohilkhand medical college and hospital |
Address |
Department of anaesthesiology
rohilkhand medical college and hospital bareilly up
Bareilly UTTAR PRADESH 243006 India |
Phone |
9720182118 |
Fax |
|
Email |
singh.himanshu9095@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Uma Rani Purohit |
Designation |
Professor |
Affiliation |
Rohilkhand medical college and hospital |
Address |
Room no 2062 d Department of Anaesthesiology rohilkhand medical college and hospital bareilly up india
Bareilly UTTAR PRADESH 243006 India |
Phone |
9927004515 |
Fax |
|
Email |
umapurohit58@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr Sarfaraz Ahmad |
Designation |
Associate professor |
Affiliation |
Rohilkhand Medical college and Hospital |
Address |
Department of anaesthesiology Rohilkhand Medical college and Hospital bareilly up
Bareilly UTTAR PRADESH 243006 India |
Phone |
7088833111 |
Fax |
|
Email |
sarfaraz_ahm2000@yahoo.com |
|
Source of Monetary or Material Support
|
Rohilkhand Medical College and Hospital Bareilly |
|
Primary Sponsor
|
Name |
Rohilkhand medical college and hospital |
Address |
Department of Anaesthesiology
Bareilly up |
Type of Sponsor |
Private medical college |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Uma Rani Purohit |
Rohilkhand Medical College and Hospital |
Department of Anaesthesiology
Bareilly UTTAR PRADESH |
9927004515
umapurohit58@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
INSTITUTIONAL ETHICS COMMITTEE RMCH BAREILLY UP |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: O||Medical and Surgical, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Comparator Agent |
DICLOFENAC |
GROUP A TRANSDERMAL DICLOFENAC PATCH of size 20 cm square containing 100 mg of diclofenac to be applied 2 hours before induction,pain relief checked for next 24 hours.total duration of intervention is for one year. |
Intervention |
INJECTION DICLOFENAC 75 MG |
GROUP B INJECTION DICLOFENAC 75 mg 30 minutes before extubation stat dose by intramuscular route.Total duration for intervention is for one year |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
60.00 Year(s) |
Gender |
Both |
Details |
American society of Anaesthesiologist (ASA) grade I or II.
Age group Between 18-60 yrs of either sex |
|
ExclusionCriteria |
Details |
Pregnant females.
Patients with co-morbid diseases like diabetes, hypertension, TB, HIV, neurological,psychiatric or neuro-vascular disorders.
Patients with history of asthma,urticaria and hypersensitivity to any component of diclofenac patch or injection.
Patients with gastrointestinal tract related problems(gastritis, ulcers, bleeding & perforation).
Patients with skin diseases (eczema, fungal infection, inflammation, burn wound).
Patients with history of alcohol abuse, blood (porphyria, bleeding or clotting disorders) and vascular disorder.
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
Blinding/Masking
|
Outcome Assessor Blinded |
Primary Outcome
|
Outcome |
TimePoints |
To compare the analgesic effect between transdermal patch of diclofenac and intramuscular diclofenac.
To document adverse effects.
To assess requirement of rescue analgesia.
To compare VAS and QoR-15 score for one year
|
To compare the analgesic effect between transdermal patch of diclofenac and intramuscular diclofenac at 2,4,6,8,10,12,24 hours.
To document adverse effects at 2,4,6,8,10,12,24 hours.
To assess requirement of rescue analgesia at 2,4,6,8,10,12,24 hours.
To compare VAS score at 2,4,6,8,10,12,24 hours and QoR-15 score after 24 hours. Total Duration for one year
|
|
Secondary Outcome
|
Outcome |
TimePoints |
NIL |
NIL |
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
22/10/2023 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
N/A |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
To compare the efficacy of transdermal patch of diclofenac with intramuscular diclofenac for post operative analgesia in laparoscopic cholecystectomy patients. Pain is the most usual symptom for which a patient seeks medical help.The International Association for the study of pain has described pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damageâ€. Commonly opioids and NSAIDs are used in peri-operative period to reduce the pain.Diclofenac sodium is a most common prescribed NSAID,which shows anti-inflammatory,analgesic and anti-pyretic activity. Mechanism of NSAID action is to reduce peripheral pain by blocking the enzyme cyclooxygenase, which transforms arachidonic acid to prostaglandins.Prostaglandins are chief mediators of inflammatory reaction and stimulate peripheral pain receptors.Diclofenac is available in various forms like injectable agents, topical gel application, ophthalmic solution, rectal suppository and transdermal patch to cure pain. There are less number of studies regarding control of acute post-operative pain of laparoscopic cholecystectomy using diclofenac transdermal patch and intramuscular diclofenac in this region.4Hence to gain further information,the present study is being conducted to compare efficacy of intramuscular diclofenac injection and transdermal diclofenac patch in post laparoscopic cholecystectomy pain management. |